Aragon Pharmaceuticals, Inc. et al v. Hetero Labs Limited Unit V et al > Summary
Court Case Number 1:22-cv-00696
Filing Date May 27, 2022
Termination Date Aug 16, 2022
Court Delaware District Court
Status Dismissed - Voluntarily
JudgesColm F. Connolly
Plaintiff
5Defendant
Plaintiff Attorneys
8Aragon Pharmaceuticals, Inc.
Attorney Name: Jeremy A. Tigan
Morris Nichols Arsht & Tunnell
Janssen Biotech, Inc.
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Janssen Biotech, Inc.
Attorney Name: Jeremy A. Tigan
Morris Nichols Arsht & Tunnell
The Regents of the University of California
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
The Regents of the University of California
Attorney Name: Jeremy A. Tigan
Morris Nichols Arsht & Tunnell
Memorial Sloan Kettering Cancer Center
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Memorial Sloan Kettering Cancer Center
Attorney Name: Jeremy A. Tigan
Morris Nichols Arsht & Tunnell
Defendant Attorneys
2Hetero
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
Hetero
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10849888 | Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | Dec 1, 2020 |
| 10702508 | Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer | Jul 7, 2020 |
| 10052314 | Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | Aug 21, 2018 |
| 09884054 | Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | Feb 6, 2018 |
| 09481663 | Crystalline forms of an androgen receptor modulator | Nov 1, 2016 |
| 08445507 | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases | May 21, 2013 |
